Skip to content
Screener

Perrigo Company PRGO Women's Health — Net Sales

Other product segments

Oral Care
$354.4M-5.4%
Upper Respiratory
$178.4M-1.6%
Skin Health
$161.8M
Healthy Lifestyle
$157.8M+2.0%
Pain & Sleep
$124.6M
Digestive Health
$115.7M-3.4%

Similar metrics at other companies

Macy's logo
MWomen's Apparel — Net Sales
$1.14B+4.1%
Designer Brands logo
DBIWomen's footwear — Net Sales
$297.71M+1.0%
Macy's logo
MWomen's Accessories, Shoes, Cosmetics and Fragrances — Net Sales
$1.99B+2.2%
Nature's Sunshine Products logo
NATRGeneral health — Net Sales
$48.9M+3.2%
Macy's logo
MMen's and Kids' — Net Sales
$965M+1.5%
Oil-Dri Corporation of America logo
ODCAnimal Health & Nutrition — Net Sales
$6.36M+10.2%

Other financials

Income statement

See full
Revenue$1.0B-3.2%
Gross profit$313.9M-13.5%
Operating income$23.5M-48.2%
Net income$74.5M+987%
EPS (diluted)$0.53+983%

Balance sheet

See full
Cash & equivalents$399.7M-12.0%
Total debt$3.5B-10.3%
Total equity$2.5B-43.7%
Total assets$7.6B-24.6%

Cash flow

See full
Operating cash flow-$113.6M-76.1%
CapEx$14.3M-25.5%
Free cash flow-$127.4M-41.6%

Valuation

See full
Market cap$1.74B-46.4%
Enterprise value$4.82B-27.7%
P/S0.4×-0.3×

Profitability

See full
Gross margin33.3%-2.5pp
Operating margin-37.7%-44.3pp
Net margin-41.9%-43.9pp
FCF margin4.2%-2.0pp

Returns & leverage

See full
Return on equity-49.6%-51.6pp
Debt / equity1.4×+0.5×
Current ratio2.3×0.0×

Where this comes from

Reported directly by Perrigo Company in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

The source filing: Perrigo Company’s 10-Q, filed August 5, 2026.

Filed
Aug 5, 2026, 1:44 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001585364-26-000145
Line itemThree Months Ended / June 27, 2026Three Months Ended / June 28, 2025Six Months Ended / June 27, 2026Six Months Ended / June 28, 2025
Total Self Care$576.6$598.6$1,119.9$1,212.8
Specialty Care
Skin Health$161.8$170.3$313.7$319.9
Women's Health64.862.7119.9112.3
Total Specialty Care$226.6$233.1$433.6$432.2
Infant Formula$100.9$82.0$190.6$169.8
All Other(1)$118.6$142.7$247.8$285.4
Total net sales$1,022.8$1,056.3$1,992.0$2,100.2

ITEM 1. FINANCIAL STATEMENTS (UNAUDITED)

FAQ

What is Perrigo Company's women's health — net sales?
Perrigo Company (PRGO) reported women's health — net sales of $64.8M in Q2 2026.
How has Perrigo Company's women's health — net sales changed year-over-year?
Perrigo Company's women's health — net sales increased by 3.3% year-over-year, from $62.7M to $64.8M.
What is the long-term trend for Perrigo Company's women's health — net sales?
Over 4 years (2021 to 2025), Perrigo Company's women's health — net sales has grown at a 24.3% compound annual growth rate (CAGR), from $92.7M to $221M.
What does women's health — net sales mean?
This metric represents the total revenue generated from the sale of products specifically categorized within the Women's Health business segment. It reflects the market demand and commercial performance of the company's specialized portfolio focused on reproductive, hormonal, and related therapeutic health solutions. Tracking this figure allows investors to evaluate the growth trajectory and competitive positioning of the company's dedicated women's health franchise.

Ask your AI about Perrigo Company's women's health — net sales.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude